Clinical Trials
4 trialsNCT05229588 2025-08-15
Lurbinectedin in Patients With Advanced Gastrointestinal Malignancies With DNA Repair Mutations
HonorHealth Research Institute
Phase 2 Completed
NCT07104175 2025-08-05
Predictive Value of NRS2002 and GLIM for Complications After GI Malignancy Surgery
Third central hospital of Tianjin affiliated Nankai university
Completed
NCT06644274 2024-12-11
The Value of 68Ga-grazytracer PET in Monitoring Responses to Immunotherapy of Gastrointestinal Malignancies
Ruijin Hospital
Recruiting
NCT03749083 2019-07-08
A Study of the Role of Circulating Tumor DNA in Predicting the Likelihood of Organ Preservation After Clinical Complete Response to Neoadjuvant Therapy for Rectal Cancer
Massachusetts General Hospital
Withdrawn